CI_ChemClass CI_with has_DoseForm has_Ingredient has_MoA has_PE may_treat drug associated with AE Cardiac Output, Low [Disease/Finding] Hypersensitivity [Disease/Finding] Discrete Subaortic Stenosis [Disease/Finding] Sulfites [Chemical/Ingredient] Positive Chronotropy [PE] Positive Inotropy [PE] Adrenergic beta1-Agonists [MoA] [AU100] SYMPATHOMIMETICS (ADRENERGICS) Injectable Solution [Dose Form] DOBUTAMINE HYDROCHLORIDE DOBUTAMINE HCL 12.5MG/ML INJ [VA Product] MG/ML C39810 盐酸多巴酚丁胺注射液 VA Product <Product_Component>DOBUTAMINE HYDROCHLORIDE</Product_Component><Strength>12.5</Strength><Unit>MG/ML</Unit><VA.IEN>134</VA.IEN> 204395 注射用盐酸多巴酚丁胺 DOBUTAMINE HCL 12.5MG/ML INJ N0000149567 盐酸多巴酚丁胺葡萄糖注射液 0 <VANDF_Record>50.68^702^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>702</VA_IEN><VA_Status>Active/Master</VA_Status> Dobutamine 12.5 MG/ML Injectable Solution DOBUTAMINE INJ DOBUTAMINE HCL 12.5MG/ML INJ C0702304 12.5 4001313 Dobutamine Hydrochloride [Chemical/Ingredient] phlebitis AE angina pectoris AE dyspnea AE headache AE hypertension AE chest pain AE palpitation AE hypotension AE increased heart rate AE nausea AE Glascow coma scale abnormal AE tachypnea AE thrombocytopenia AE ventricular extrasystoles AE skin necrosis AE ventricular ectopic beats AE sudden fall of blood pressure AE serum potassium concentration of moderately reduced DOBUTAMINE HCL 12.5MG/ML INJ [VA Product] DOBUTAMINE HCL 12.5MG/ML INJ 盐酸多巴酚丁胺注射液 VA Product N0000149567 <Product_Component>DOBUTAMINE HYDROCHLORIDE</Product_Component><Strength>12.5</Strength><Unit>MG/ML</Unit><VA.IEN>134</VA.IEN> MG/ML <VANDF_Record>50.68^702^Active/Master</VANDF_Record><VA_File>50.68</VA_File><VA_IEN>702</VA_IEN><VA_Status>Active/Master</VA_Status> Dobutamine 12.5 MG/ML Injectable Solution 盐酸多巴酚丁胺葡萄糖注射液 204395 C39810 DOBUTAMINE INJ DOBUTAMINE HCL 12.5MG/ML INJ 0 C0702304 注射用盐酸多巴酚丁胺 12.5 4001313